Pulmonology | Pulmonology and Critical care | Pulmonology webinar 2021 | Respiratory Conferences | Asia Pacific | conference series

Theme:

Pulmonary Meet 2021

Pulmonary Meet 2021

About Conference:

Inviting all the participants over the globe to the “9th Annual Congress on Pulmonary and Critical Care” which is scheduled virtually during November 22-23, 2021. Pulmonary meet 2021 Conference is based on the theme “Advanced Treatment in Pulmonology".

The aim of this conference is to learn and share innovative ideas and developments on current research by gathering leading worldwide researchers, industry researchers, scholars, decision-makers, and other professionals in pulmonology and Critical care. Pulmonary Meet 2021 conference is going to be one of the most remarkable events of the year.

Pulmonary meet 2021 welcome Pulmonologists, Respiratory Care Practitioners (RCP), and Respiratory Medicine specialists across the globe to discuss current trends in respiratory disease screening to diagnosis, treatment, and management. Strategic sessions of Pulmonary & Respiratory Medicine covering about almost all of the Respiratory Diseases such as COPD, asthma, allergy, cystic fibrosis, pneumonia, tuberculosis, emphysema, lung cancers, complicated chest infections, pulmonary fibrosis, sleep apnea, interstitial lung disease, lung nodules, chronic cough, influenza, mycobacterial infection, pediatric pulmonary, bronchiectasis, critical care, etc. and also health care discipline specializing in the promotion of optimum cardiopulmonary function, health, and wellness.

Pulmonary meet 2021 will entail world-class keynote talks, speakers presenting their research works in the form of oral and poster presentations with interactive networking sessions, one-to-one meetings, exhibitor presentations, and workshops.

Who can attend?

Thousands of pulmonary professionals gather to learn and present the latest advances in the rapidly evolving field of pulmonary medicine during the International Conference. When intensivist is able to make time in their demanding schedules, thousands choose to attend the International Conference where they know they will find the most relevant program content in their fields

This Conference is the home of pulmonary, critical care, and professionals, from those in the earliest stages of their careers to those whose research or strides in clinical care has gained them international recognition. Each year, nearly 14,000 of these professionals choose to attend, present, and learn about the latest advances, meet with colleagues from around the world, and strike new collaborations. It is truly where today’s science meets tomorrow’s care.

The International Conference is also multidisciplinary. Clinicians and researchers in many other fields attend the conference, thereby enriching conversations that lead to insights that ultimately improve patient care.

Equally important, this International Conference gathers the entire health care team in one place to share ideas across these medical and scientific disciplines. It is the ideal place for registered nurses, advanced practice nurses, respiratory therapists, and hospitalists to discuss their experiences, challenges, and research so that all can learn about the latest advances in understanding pulmonary disease, critical illness, and other disorders.

Why to attend?

Meet your objectives from around the world addressed about Pulmonology and Critical care. This is every so often a single finest chance to complete the utmost significant meeting of members from the Research Institutions, Universities, Clinics and Hospitals. Distribute Data and Conduct demonstrations, meet with present potential speakers, create a splash with supplementary products, and receive name recognition at this 2-day event. World renowned speakers, interesting techniques, latest updates in pulmonology and critical care and stimulating the field of genuine extent hallmarks of this conference Attending International conference is about bringing professional development and to get the existing state of research and the trials to future discovery. The goal of this convention is to stimulate new thoughts for remedy with a purpose to be useful throughout the spectrum of pulmonologists.

What’s New?

Pulmonary medicine offers the opportunity for continuity care in dealing with patients with chronic lung disease as well as certain diagnostic challenges. Pulmonary medicine also requires a sound understanding of physiology. Pulmonologists are likely to perform and interpret pulmonary function tests, cardiopulmonary exercise tests and sleep studies as part of practice. Outpatient procedures, including diagnostic and therapeutic bronchoscopy, can make up a significant portion of some pulmonary practices.

Pulmonary meet 2021 invites participants from all foremost clinics, universities, clinical research institutions to segment their research experiences on all phases of this rapidly expanding stream and thereby, providing a platform of the newest research and provide a better health care to the world. It is also intended for practicing pulmonologists, nurses, physicians in training and other healthcare professionals concerned in the latest advances and techniques in the field. Another segment of contestants is critical care researchers, Clinical organizations, Educational institutes, and Business leaders in the health sector worldwide.

Target Audience:

Sessions / Tracks

Track 01: Pulmonology & Critical care:

Pulmonary medicine may be a subspecialty of general medicine that focuses on the prevention, diagnosis, and treatment of conditions that affect the lungs and tract. Here are a number of the foremost common conditions that our pulmonologists diagnose and treat: Asthma

Critical Care may be a high-quality, peer-reviewed, international clinical medical journal. Critical Care aims to enhance the care of critically ill patients by acquiring, discussing, distributing, and promoting evidence-based information relevant to intensivist. Critical Care aims to supply a comprehensive overview of the medical care field.

Bronchiectasis
Bronchitis
Chronic obstructive pulmonary disease (COPD)t
Interstitial lung disease
Occupational lung disease
Pulmonary fibrosis
Rheumatoid lung disease
Sarcoidosis

Track 02: Cardio Pulmonary Disorders:

The term cardiopulmonary disease describes a variety of conditions that affect the guts and lungs. These organs are closely connected, and a drag in one can spill over to the opposite. For instance, when the guts aren’t ready to pump blood efficiently, normal oxygen movement within the lungs is reduced, causing shortness of breath. On the opposite hand, a drag with the lungs can cause the guts to possess to figure harder to urge oxygen from the lungs into the blood.

Chronic bronchitis
Chronic Obstructive Pulmonary Disease (COPD)
Congestive heart failure
Emphysema

Track 03: Emphysema:

Emphysema is a condition that involves damage to the walls of the air sacs (alveoli) of the lung. Alveoli are small, thin-walled, very fragile air sacs located in clusters at the end of the bronchial tubes deep inside the lungs. There are about 300 million alveoli in normal lungs.

Shortness of breath, especially during light exercise or climbing steps

Ongoing feeling of not being able to get enough air
Long-term cough or “smoker’s cough”
Wheezing
Long-term mucus production
Ongoing fatigue

Track 04: Allergic diseases:

Allergies, also referred to as allergic diseases, are variety of conditions caused by hypersensitivity of the system to typically harmless substances within the environment. These diseases include pollinosis, food allergies, atopic eczema, allergic asthma, and anaphylaxis.

Common allergens include pollen and certain foods. Metals and other substances can also cause such problems. Food, insect stings, and medications are common causes of severe reactions. Their development is thanks to both genetic and environmental factors. The underlying mechanism involves immunoglobulin E antibodies (IgE), a part of the body's system, binding to an allergen then to a receptor on mast cells or basophils where it triggers the discharge of inflammatory chemicals like histamine.

Track 05: Chronic Obstructive Pulmonary Disease:

Chronic obstructive Pulmonary Disease (COPD) may be a chronic inflammatory lung disease that causes obstructed airflow from the lungs. Symptoms include breathing difficulty, cough, mucus (sputum) production and wheezing. It's typically caused by long-term exposure to irritating gases or particulate, most frequently from cigarette smoke. People with COPD are at increased risk of developing heart condition, carcinoma and a spread of other conditions.

Emphysema and bronchitis are the two commonest conditions that contribute to COPD. These two conditions usually occur together and may vary in severity among individuals with COPD.

Chronic bronchitis is inflammation of the liner of the bronchial tubes, which carry air to and from the air sacs (alveoli) of the lungs. It's characterized by daily cough and mucus (sputum) production.

Track 06: Pulmonary Hypertension:

Pulmonary hypertension may be a sort of high vital sign that affects the arteries in your lungs and therefore the right side of your heart.

In one sort of pulmonary hypertension, called pulmonary arterial hypertension (PAH), blood vessels in your lungs are narrowed, blocked, or destroyed. The damage slows blood flow through your lungs, and vital sign within the lung arteries rises. Your heart must work harder to pump blood through your lungs. The extra effort eventually causes your cardiac muscle to become weak and fail.

Pulmonary arterial hypertension (PAH)
Pulmonary hypertension caused by left-sided heart disease
Pulmonary hypertension caused by lung disease
Pulmonary hypertension caused by chronic blood clots
Pulmonary hypertension triggered by other health conditions
Eisenmenger syndrome and pulmonary hypertension

Track 07: Tuberculosis:

Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Many tuberculosis strains resist the drugs most used to treat the disease. People with active tuberculosis must take many types of medications for months to get rid of the infection and prevent antibiotic resistance.

Track 08: Lung Problems:

Lung disease is any problem within the lungs that forestalls the lungs from working properly. There are three main kinds of lung disease:

Airway diseases -- These diseases affect the tubes (airways) that carry oxygen and other gases into and out of the lungs. They typically cause a narrowing or blockage of the airways. Airway diseases include asthma, COPD and bronchiectasis. People with airway diseases often say they feel as if they're "trying to exhale through a straw."

Lung tissue diseases -- These diseases affect the structure of the lung tissue. Scarring or inflammation of the tissue makes the lungs unable to expand fully (restrictive lung disease). This makes it hard for the lungs to require in oxygen and release CO2. People with this sort of lung disorder often say they feel as if they're "wearing a too-tight sweater or vest." As a result, they cannot breathe deeply. Pulmonary fibrosis and Sarcoidosis are samples of lung tissue disease.

Lung circulation diseases -- These diseases affect the blood vessels within the lungs. They’re caused by clotting, scarring, or inflammation of the blood vessels. They affect the power of the lungs to require up oxygen and release CO2. These diseases can also affect heart function. An example of a lung circulation disease is pulmonary hypertension. People with these conditions often feel very in need of breath once they exert themselves.

Track 09: Asthma:

Asthma could also be a condition during which your airways narrow and swell and will produce extra mucus. This may make breathing difficult and trigger coughing, a whistling sound (wheezing) once you exhale and shortness of breath.

Signs that your asthma is probably worsening include:

Asthma signs and symptoms that is more frequent and bothersome
Increasing difficulty breathing, as measured with a tool used to check how well your lungs are working (peak flow meter)
The need to use a quick-relief inhaler more often

Exercise-induced asthma
Occupational asthma
Allergy-induced asthma

Track 10: Lung Cancer:

Lung cancer could also be a kind of cancer that begins within the lungs. Your lungs are two spongy organs in your chest that absorb oxygen once you inhale and release CO2 once you exhale.

The two general sorts of carcinoma include:

Small cell carcinoma -Small cell carcinoma occurs almost exclusively in heavy smokers and is a smaller amount common than non-small cell carcinoma.

Non-small cell carcinoma -Non-small cell carcinoma is an umbrella term for several kinds of lung cancers. Non-small cell lung cancers include epithelial cell carcinoma, adenocarcinoma, and enormous cell carcinoma

Smoking
Exposure to secondhand smoke
Previous radiation therapy
Exposure to radon gas
Exposure to asbestos and other carcinogens
Family history of lung cancer

Track 11: Pulmonary function test (PFT):

Pulmonary Function Tests (PFTs) are noninvasive tests that show how well the lungs are working. The tests measure lung volume, capacity, rates of flow, and gas exchange. This information can help your healthcare provider diagnose and choose the treatment of certain lung disorders.

There are two sorts of disorders that cause problems with air occupation and out of the lungs:

Obstructive: This is often when air has trouble flowing out of the lungs thanks to airway resistance. This causes a decreased flow of air.
Restrictive: This is often when the lung tissue and/or chest muscles can’t expand enough. This creates problems with air flow, mostly thanks to lower lung volumes.

Track 12: Respiratory and pulmonary therapies:

Pulmonary Rehabilitation to assist you breathe easier and improve your quality of life surely lung conditions like chronic obstructive pulmonary disease (COPD), asthma, pulmonary hypertension, and CF. It also can improve lifestyle for people that have scoliosis or other health problems that limit lung function. Your doctor can also recommend pulmonary rehabilitation before and after surgery for a lung transplant or carcinoma.

Track 13: Pediatric Critical Care:

Children who are critically ill require careful monitoring in a pediatric intensive care unit (PICU). Pediatric critical care specialists coordinate the care of these children which is provided by a team of doctors, nurses, and other health care specialists. They use the special medicines or treatments that can only be offered in the PICU.

Pediatric critical care specialists generally provide the following care to children who are critically ill:

Diagnosis of children who have an unstable, life-threatening condition
Thorough monitoring, medication, and treatment of children in a PICU
Supervision of children on ventilators
Medical treatment for children with severe heart and lung disease
Placement of special catheters in the blood vessels and heart
Management of medications and treatments for children with brain trauma

Track 14: Pulmonary Rehabilitation:

Pulmonary rehabilitation, also known as respiratory rehabilitation, is an important part of the management and health maintenance of people with chronic respiratory disease who remain symptomatic or continue to have decreased function despite standard medical treatment. It is a broad therapeutic concept. It is defined by the American Thoracic Society and the European Respiratory Society as an evidence-based, multidisciplinary, and comprehensive intervention for patients with chronic respiratory diseases who are symptomatic and often have decreased daily life activities. In general, pulmonary rehabilitation refers to a series of services that are administered to patients of respiratory disease and their families, typically to attempt to improve the quality of life for the patient. Pulmonary rehabilitation may be carried out in a variety of settings, depending on the patient's needs, and may or may not include pharmacologic intervention.

Track 15: Pleural Diseases:

Pleurisy - an infection of the pleural cavity. Pleural effusion - the buildup of pleural fluid in the pleural cavity. Pneumothorax - the presence of air or gas in the pleural cavity. Hem thorax - the presence of blood in the pleural cavity. Many different conditions can cause pleural problems. Viral infection is the most common cause of pleurisy. The most common cause of pleural effusion is congestive heart failure. Lung diseases, like COPD, tuberculosis, and acute lung injury, cause pneumothorax. Injury to the chest is the most common cause of hem thorax. Treatment focuses on removing fluid, air, or blood from the pleural space, relieving symptoms, and treating the underlying condition.

Track 16: End-of-Life Care:

End-of-life care (EoLC) refers to health care for a person nearing the end of their life or in the advanced stage of a terminal illness. Generally speaking, people who are dying need care in four areas—physical comfort, mental and emotional needs, spiritual issues, and practical tasks.

End-of-life care involves a range of possible decisions, including hospice care, palliative care, patients' rights to choose, participation in clinical trials and choice of medical interventions, including continuance of routine medical interventions. Such decisions are informed by medical, financial and ethical considerations.

In most advanced countries, medical spending on people in the last twelve months of life makes up roughly 10% of total aggregate medical spending, while those in the last three years of life can cost up to 25%.

Market Analysis:

Critical care, or intensive care, is the branch of medicine concerned with life threatening injuries or illnesses. Usually taking place in a critical or intensive care unit (CCU or ICU) or trauma center, specially trained health professionals meet the needs of critical patients by treating complications of surgery, accidents, infections and severe breathing problems.

Equipment used in a CCU is designed to care for patients requiring 24-hour care and monitoring. This consists of life support and emergency resuscitation devices, equipment for patient monitoring, pain management devices and equipment for respiratory and cardiac support.

Patient monitoring equipment includes acute care physiologic monitoring systems that continuously measure vital signs, pulse oximeters to monitor oxygen saturation in the blood, intracranial pressure monitors which measure fluid pressure in the brain and apnea monitors used for continuous monitoring of breathing to detect cessation in infants and adults at risk of respiratory failure.

The market was valued at US$ 18,598.56 million in 2019 and is projected to reach US$ 39,965.01 million by 2027 and is expected to grow at a CAGR of 10.1% during 2020-2027.Equipment used in the CCU for life support and emergency resuscitation include ventilators (or respirators) which aid in pulmonary ventilation in patients who cannot breathe on their own, infusion pumps to deliver anesthesia, medications and blood infusions, crash carts containing emergency resuscitation devices such as defibrillators, airway intubation devices and resuscitation masks, and intra-aortic balloon pumps used for patients with myocardial infarction, unstable angina and those awaiting transplants.

Market for Consumables and Accessories to Grow at Highest CAGR during 2020-2027.

The global pulmonary devices market, based on type, is segmented into therapeutic devices, consumables and accessories, diagnostic devices, and monitoring devices. The therapeutic devices segment held the largest share of the market in 2019, and this growth is ascribed to the increasing demand of inhalers and nebulizers by patients suffering with asthma and chronic obstructive pulmonary disorders.

However, the consumables and accessories segment is estimated to register the highest CAGR during the forecast period. Also, the impact of the COVID-19 crisis is expected to further accelerate the growth of the respiratory devices market. Critical care devices are being manufactured in increased quantities to meet growing demand. The state of affairs resulting from the pandemic has resulted in alliances between healthcare and non-healthcare industries to manufacture respiratory care devices.

Moreover, the US FDA has authorized the use of CPAP and similar devices to help cover the forecasted shortage of ventilators in COVID-19 treatment.

The growth of the pulmonary devices market is attributed to factors such as rising number of COVID-19 cases worldwide and increasing prevalence of respiratory diseases. However, the unfavorable reimbursement scenario associated with the respiratory devices restrains the growth of the market.

Past Conference Report:

Conference series LLC Ltd successfully hosted “8th Annual Congress on Pulmonary and Critical Care" during December 07-08, 2020 Tokyo, Japan. PULMONARY MEET 2020 conference was organized around the theme “Optimizing Research Strategies for Lung Disorder Treatments" and it was a great success where eminent keynote speakers from various reputed organizations made their resplendent presence and addressed the gathering.

PULMONARY MEET 2020 was marked by the attendance of Editorial Board Members of supported Journals like Journal of Pulmonary & Respiratory Medicine, Journal of Lung Diseases & Treatment and Journal of Pulmonary Medicine. Many Scientists, young and brilliant Researchers, Business Delegates and talented Student Communities representing from varies countries made this conference fruitful and productive driving the event into the path of success with thought provoking keynote and plenary presentations.

With the feedback from the participants and supporters of PULMONARY MEET 2020, Conference series LLC Ltd is glad to announce "9th Annual Congress on Pulmonary and Critical Care" (Pulmonary meet 2021) during November 22-23, 2021 Webinar. Pulmonary meet 2021 will cover some of the most challenging topics and advancements in research in the fields of Pulmonary and Critical care.

Let us meet again @ Pulmonary Meet 2021

Conference Highlights

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date	November 22-23, 2021
Sponsors & Exhibitors	~~Click here for Sponsorship Opportunities~~
Speaker Opportunity Closed
Poster Opportunity Closed	Click Here to View

Useful Links

Special Issues

All accepted abstracts will be published in respective Our International Journals.

Abstracts will be provided with Digital Object Identifier by

9^th Annual Congress on Pulmonary and Critical Care November 22-23, 2021 Singapore City,Singapore

Recommended Global Oncology & Cancer Conferences

USA & Americas

Europe & Middle East

Asia Pacific

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

We warmly invite you to submit your abstract and attend the 9^th Annual Congress on Pulmonary and Critical Care.

Pulmonary Meet 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues

Meet Inspiring Speakers and Experts at our 1000+ Global Events inclusive of 300+ Conferences, 500+ Workshops and 200+ Symposiums Every year on Medical, Pharma, Engineering, Science, Technology and Business.

For more Conferences visit www.conferenceseries.com

Quick Links

We warmly invite you to submit your abstract and attend the 9th Annual Congress on Pulmonary and Critical Care.

Pulmonary Meet 2021

Conference Highlights

To Collaborate Scientific Professionals around the World

Useful Links

Special Issues

We warmly invite you to submit your abstract and attend the 9^th Annual Congress on Pulmonary and Critical Care.